A new trading day began on Monday, with Pfizer Inc (NYSE: PFE) stock price up 0.25%% from the previous day of trading, before settling in for the closing price of $23.97. PFE’s price has ranged from $20.92 to $31.54 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -13.25%. Meanwhile, its annual earnings per share averaged -3.50%. With a float of $5.67 billion, this company’s outstanding shares have now reached $5.68 billion.
Let’s determine the extent of company efficiency that accounts for 81000 employees. In terms of profitability, gross margin is 67.39%, operating margin of 23.65%, and the pretax margin is 11.83%.
Pfizer Inc (PFE) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – General Industry. The insider ownership of Pfizer Inc is 0.18%, while institutional ownership is 67.07%. The most recent insider transaction that took place on May 23 ’25, was worth 1,380,632. Before that another transaction happened on May 05 ’25, when Company’s Former Officer proposed sale 55,000 for $23.87, making the entire transaction worth $1,312,736.
Pfizer Inc (PFE) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -3.50% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.27% during the next five years compared to -13.25% drop over the previous five years of trading.
Pfizer Inc (NYSE: PFE) Trading Performance Indicators
Here are Pfizer Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.96. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.19. Likewise, its price to free cash flow for the trailing twelve months is 12.18.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.38, a number that is poised to hit 0.57 in the next quarter and is forecasted to reach 3.09 in one year’s time.
Technical Analysis of Pfizer Inc (PFE)
Looking closely at Pfizer Inc (NYSE: PFE), its last 5-days average volume was 41.53 million, which is a drop from its year-to-date volume of 46.77 million. As of the previous 9 days, the stock’s Stochastic %D was 31.85%.
During the past 100 days, Pfizer Inc’s (PFE) raw stochastic average was set at 49.25%, which indicates a significant decrease from 51.32% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 18.25% in the past 14 days, which was lower than the 26.77% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $23.22, while its 200-day Moving Average is $25.93. However, in the short run, Pfizer Inc’s stock first resistance to watch stands at $24.16. Second resistance stands at $24.28. The third major resistance level sits at $24.48. If the price goes on to break the first support level at $23.84, it is likely to go to the next support level at $23.64. Now, if the price goes above the second support level, the third support stands at $23.52.
Pfizer Inc (NYSE: PFE) Key Stats
With a market capitalization of 136.62 billion, the company has a total of 5,685,366K Shares Outstanding. Currently, annual sales are 63,627 M while annual income is 8,031 M. The company’s previous quarter sales were 13,715 M while its latest quarter income was 2,967 M.
